SCHEMBL22014833

SCHEMBL22014833

NCCS(=O)(=O)CC(=O)N1C[C@@H]2CN(c3ccc(F)cc3)C[C@@H]2C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.40
NPC1 O15118 2/20 0.40
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
SMN1; SMN2 Q16637 6/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
LMNA P02545 2/20 0.39
GAA P10253 1/20 0.39
HBB P68871 1/20 0.39
POLB P06746 2/20 0.39
EIF4H Q15056 1/20 0.38
CHRM1 P11229 1/20 0.38
HPGD P15428 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
NOTUM Q6P988 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22014825 0.88 SMN1; SMN2 (0.38) SMN1; SMN2MEN1KMT2ALMNAGAA
SCHEMBL22014827 0.88 KMT2A (0.46) SMN1; SMN2MEN1KMT2ALMNACHRM1
SCHEMBL22014820 0.83 ACACB (0.40) SMN1; SMN2MAPT
SCHEMBL22014834 0.81 KMT2A (0.30) KMT2A
SCHEMBL22014824 0.79 CHRM1 (0.36) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL24209303 0.78 CYP1A2 (0.39) RAB9ANPC1HDAC1HDAC2SMN1; SMN2
SCHEMBL22014822 0.73 NPC1 (0.48) RAB9ANPC1KMT2ALMNAGAA
SCHEMBL25389906 0.72 NOTUM (0.51) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL25390551 0.72 NOTUM (0.51) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL17134643 0.72 NOTUM (0.51) RAB9ANPC1SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020099886-A1 LOX INHIBITORS THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) 2020-05-22 WO disclosed